Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2008
10/02/2008US20080241152 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof
10/02/2008US20080241151 Neisserial peptides for use in developing vaccine for prevention and treatment of menigococcal septicemia and meningitis
10/02/2008US20080241150 Peptide comprising Lin12-Notch repeats (LNR) for use in identifying and designing modulators for prevention and treatment of cell proliferative disorders
10/02/2008US20080241147 Using pleckstrin homology (PH) domain-interacting protein as tool in detection and identification of modulators for prevention and treatment of cell proliferative disorders
10/02/2008US20080241146 Apo-2 ligand-anti-Her-2 antibody synergism
10/02/2008US20080241143 Using selectin therapeutic in treatment of inflammatory bowel and joint disorders
10/02/2008US20080241142 Neuropilin/VEGF-C/VEGFR-3 Materials and Methods
10/02/2008US20080241138 Soluble il-17ra/rc fusion proteins and related methods
10/02/2008US20080241133 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
10/02/2008US20080241124 Nucleotide sequences coding g-protein couple receptor for use in identifying modulators for prevention and treatment of inflammation, sarcoidosis and rheumatoid arthritis
10/02/2008US20080241114 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or T cell subset activity by modulation of XBP-1 activity
10/02/2008US20080241108 Bone Morphogenic Protein Binding Peptide
10/02/2008US20080241104 Espfu nucleic acids and proteins and uses thereof
10/02/2008US20080241099 Inhibitors of MBP 85-99 or proteolipid protein (PLP) 40-60-specific HLA-DR-2-restricted T cell clones; multiple sclerosis; rheumatoid arthritis; solid phase synthesis; kits
10/02/2008US20080241096 IL-1 family variants
10/02/2008US20080240982 Solid substrate on which a physiologically active substance is immobilized
10/02/2008DE102007015583A1 Ein Enzym zur Herstellung von Methylmalonyl-Coenzym A oder Ethylmalonyl-Coenzym A sowie dessen Verwendung An enzyme for the production of methylmalonyl-coenzyme A or ethylmalonyl-coenzyme A and the use thereof
10/02/2008DE10101430B4 Lösliche cyclische Analoga zur Modulation der Amyloidogenese Soluble cyclic analogues in the modulation of amyloidogenesis
10/02/2008CA2682516A1 Schizophrenia-related isoform of kcnh2 and development of antipsychotic drugs
10/02/2008CA2682503A1 Cartilage intermediate layer protein 2 c1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions
10/02/2008CA2682045A1 Method of eliciting immune response with a modified mva viral hiv-1 vector
10/02/2008CA2681924A1 Improved vaccines against bordetella pertussis based on lps glycosyltransferase mutants
10/02/2008CA2681921A1 Peptides with anitfungal activity
10/02/2008CA2681917A1 Methods and compositions for treating prostate cancer
10/02/2008CA2681594A1 Aerated food products being warm or having been heated up and methods for producing them
10/02/2008CA2681567A1 Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
10/02/2008CA2681132A1 Prame derived peptides and immunogenic compositions comprising these
10/02/2008CA2680837A1 Mek ligands and polynucleotides encoding mek ligands
10/02/2008CA2680832A1 Method for detecting autoprocessed, secreted pcsk9
10/02/2008CA2680046A1 Methods of diagnosing, classifying and treating endometrial cancer and precancer
10/02/2008CA2679588A1 Soluble il-17ra/rc fusion proteins and related methods
10/02/2008CA2679332A1 Polypeptide recognized by anti hiv-1 gp41 antibodies isolated from highly hiv-1 exposed, non infected women
10/01/2008EP1975622A1 Reagent for measuring clotting time and method for stabilizing tissue factor
10/01/2008EP1975620A2 Three hybrid assay system
10/01/2008EP1975614A1 Method for prediction of prognosis of acute coronary syndrome
10/01/2008EP1975235A2 Porcine circovirus vaccine in recombinant poxvirus
10/01/2008EP1975234A2 Therapeutic and diagnotics agents capable of modulating cellular responsiveness to cytokines
10/01/2008EP1975233A1 Nucleic acid binding proteins
10/01/2008EP1975231A1 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
10/01/2008EP1975181A1 Use of vascular endothelial cell growth factor antagonists
10/01/2008EP1975177A1 An appetite-suppressing peptide, its compositions and use
10/01/2008EP1975176A1 Novel glp-1 fusion peptides, their production and use
10/01/2008EP1975175A2 IgA nephropathy-related DNA
10/01/2008EP1975174A1 Selective peptides that inhibit the biological activity of calcineurin
10/01/2008EP1975173A1 Anti-Retroviral Immunogens, Preparation and Use
10/01/2008EP1975172A2 High affinity TGFß nucleic acid ligands and inhibitors
10/01/2008EP1974752A1 Subcellular targeting of therapeutic proteins
10/01/2008EP1974750A1 Preventive or therapeutic agent and method for immune disease
10/01/2008EP1974744A1 Immunization through oral administration of a vaccine with an edible product
10/01/2008EP1974738A2 Diagnostics and therapeutics for glaucoma
10/01/2008EP1974212A1 Compounds useful in cftr assays and methods therewith
10/01/2008EP1974040A2 Compositions and methods for humanization and optimization of n-glycans in plants
10/01/2008EP1974023A1 Dengue chimeric viruses
10/01/2008EP1973944A1 Fgf2-binding peptides and uses thereof
10/01/2008EP1973943A1 New method for the treatment of gout or pseudogout
10/01/2008EP1973942A2 Recombinant production of heparin binding proteins
10/01/2008EP1973941A2 Compositions and methods for inhibiting viral adhesion
10/01/2008EP1973940A2 Compositions and methods for humanization and optimization of n-glycans in plants
10/01/2008EP1973939A2 A novel binding site for retigabine on kcnq5
10/01/2008EP1973938A2 Luminescent stem cells and uses thereof
10/01/2008EP1973937A1 Luminescent transgenic non human animals, progeny, cell derivatives and uses thereof
10/01/2008EP1973936A1 Reeler domain containing protein
10/01/2008EP1973935A2 Expression control elements from the lemnaceae family
10/01/2008EP1973934A1 Polypeptides
10/01/2008EP1973933A1 A NOVEL SURFACE EXPOSED HAEMOPHILUS INFLUENZAE PROTEIN (PROTEIN E; pE)
10/01/2008EP1973932A2 Twin-arginine translocation (tat) streptomyces signal sequences
10/01/2008EP1973931A2 Chicken virus vaccine and diagnostic
10/01/2008EP1973567A1 Hypoallergenic variants of the major allergen from betula verrucosa pollen
10/01/2008EP1973563A1 Method for the purification of alpha-1-antitrypsin
10/01/2008EP1973556A2 Histidine-containing diastereomeric peptides and uses thereof
10/01/2008EP1812459A4 Method for the mass production of multimeric mannose binding lectin
10/01/2008EP1709161B1 Human therapeutic cells secreting nerve growth factor
10/01/2008EP1689355A4 Selective inhibitors of nuclear factor-kb activation and uses thereof
10/01/2008EP1633859B1 Cell line and uses thereof
10/01/2008EP1512740B1 Synthase of cereulide produced by bacillus cereus, gene encoding the same and method of detecting cereulide
10/01/2008EP1390397B1 Pre-s protein of hepatitis b virus (hbv) as an adjuvant and a component of hbv vaccine
10/01/2008EP1317274B1 Peptide composition for treatment of periodontal diseases and prevention of skin aging
10/01/2008EP1251172B1 Wt1-interacting protein wtip
10/01/2008EP1241933B1 Melanocortin-3 receptor deficient cells, transgenic mice and methods of selecting compounds which regulate body weight
10/01/2008EP1208111B1 Genes encoding insect odorant receptors and uses thereof
10/01/2008EP1142590B1 Gene therapy for diabetic ischemic disease
10/01/2008EP1129111B1 Methods for conversion of interferon isoforms and products thereof
10/01/2008EP1102847B1 Novel tension-dependent potassium channel and the use thereof in the development of new therapeutic agents
10/01/2008EP0804486B1 Granulocyte chemotactic protein
10/01/2008EP0766512B1 Replication-competent herpes simplex virus mediates destruction of neoplastic cells
10/01/2008CN101278050A Genes involved in the biosynthesis of thiocoraline and heterologous production of same
10/01/2008CN101277974A Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use
10/01/2008CN101277973A Guar extract-containing composition and uses of a guar extract in the form of a surface treating and/or modifying agent
10/01/2008CN101277972A Guar protein extract product and method for the production and use thereof
10/01/2008CN101277971A Vaccines against AIDS comprising CMV/R - nucleic acid constructs
10/01/2008CN101277970A Improved chimeric toxin receptor proteins and chimeric toxin receptor proteins for treatment and prevention of anthrax
10/01/2008CN101275142A Newcastle disease virus infectious clones, vaccines and diagnostic assays
10/01/2008CN101275136A Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and DNAs encoding the same
10/01/2008CN101274961A Recombinant human parathyroid hormone related protein
10/01/2008CN101274960A Genes associated with leishmania parasite virulence
10/01/2008CN101274959A Proteinase k resistant surface protein of neisseria meningitidis
10/01/2008CN101274956A Method for separating and purifying alpha 1-antitrypsin from human blood plasma component FIV precipitation
10/01/2008CN100422346C NS5A nucleotide sequence variation as a marker
10/01/2008CN100422335C Sequence regulating anther-specific expression of gene and its use in production of androsterile plants and hybrid seeds
10/01/2008CN100422332C Expression and export of angiostation and endostatin as immunofusins
1 ... 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 ... 2916